Health
Diabetes vaccine gives promising results in a genetic subgroup – EurekAlert
A clinical study led by Linköping University, Sweden, and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type…
IMAGE: Johnny Ludvigsson, senior professor at Linköping University.
view more
Credit: Anna Nilsen/Linköping University
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.
…
-
General24 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News22 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station
-
Business22 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Noosa News18 hours agoThe only person detained at Brisbane’s Palestine rally